APA

Radstake T. R. D. J., Svenson M., Eijsbouts A. M., van den Hoogen F. H. J., Enevold C., van Riel P. L. C. M. & Bendtzen K. (20091117). Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. : Annals of the rheumatic diseases.

Chicago

Radstake T R D J, Svenson M, Eijsbouts A M, van den Hoogen F H J, Enevold C, van Riel P L C M and Bendtzen K. 20091117. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. : Annals of the rheumatic diseases.

Harvard

Radstake T. R. D. J., Svenson M., Eijsbouts A. M., van den Hoogen F. H. J., Enevold C., van Riel P. L. C. M. and Bendtzen K. (20091117). Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. : Annals of the rheumatic diseases.

MLA

Radstake T R D J, Svenson M, Eijsbouts A M, van den Hoogen F H J, Enevold C, van Riel P L C M and Bendtzen K. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis. : Annals of the rheumatic diseases. 20091117.